Pancreatic Cancer Research

ResearcherMedical College of WisconsinActive in the last 2 years

Beth E. Erickson

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0009-0004-8908-5633; OpenAlex author ID A5037735248, A5039041724, A5043777487. Sources: ClinicalTrials.gov.

Their work

Papers
10
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
49
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: 1 trial · 2016: none · 2017: none · 2018: none · 2019: 3 papers · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper · 2025: 2 papers · 2026: 2 papers

Papers 10

  1. AI-Derived Electronic Tumor Marker For Cancer Antigen 19-9 Nonproducers With Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1001/jamasurg.2026.0291↗
  2. Mutant and Wild-Type RAS Cross-talk and Stoichiometric Deficiencies Are Determinants of Sensitivity to Targeted Therapies in KRASG12R Pancreatic Ductal Adenoca… Co-author DOI 10.1158/0008-5472.can-25-0018↗
  3. Quality of Life and Toxicity in Patients With Pancreatic Ductal Adenocarcinoma Treated With Online Adaptive Stereotactic Magnetic Resonance Guided Radiation Th… Co-author DOI 10.1016/j.ijrobp.2025.03.046↗
  4. Patterns of Locoregional Pancreatic Cancer Recurrence After Total Neoadjuvant Therapy and Implications on Optimal Neoadjuvant Radiation Treatment Volumes. Co-author DOI 10.1016/j.prro.2024.07.001↗
  5. Chemotherapy-free treatment targeting fusions and driver mutations in KRAS wild-type pancreatic ductal adenocarcinoma, a case series. Co-author DOI 10.1177/17588359241253113↗
  6. Value of Neoadjuvant Radiation Therapy in the Management of Pancreatic Adenocarcinoma. Co-author DOI 10.1200/jco.21.01220↗
  7. A preferred patient decubitus positioning for magnetic resonance image guided online adaptive radiation therapy of pancreatic cancer. Co-author DOI 10.1016/j.phro.2019.11.001↗
  8. A machine learning based delta-radiomics process for early prediction of treatment response of pancreatic cancer. Co-author DOI 10.1038/s41698-019-0096-z↗
  9. Improving Treatment Response Prediction for Chemoradiation Therapy of Pancreatic Cancer Using a Combination of Delta-Radiomics and the Clinical Biomarker CA19-… Co-author DOI 10.3389/fonc.2019.01464↗
  10. Weekly paclitaxel, gemcitabine, and external irradiation followed by randomized farnesyl transferase inhibitor R115777 for locally advanced pancreatic cancer. Co-author DOI 10.2147/ott.s33560↗

Trials 1

  1. MR Guided Phase II Radiotherapy Dose Escalation in Unresectable Non-Metastatic Pancreatic Cancer Principal investigator NCT01972919↗

Closest collaborators

The 25 strongest of 49 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. William Adrian Hall · 9 shared papers, 2019–2026 · strength 1.43
  2. Kathleen K. Christians · 4 shared papers, 2024–2026 · strength 0.81
  3. Mandana Kamgar · 4 shared papers, 2024–2026 · strength 0.81
  4. Susan Tsai · 5 shared papers, 2019–2026 · strength 0.80
  5. Douglas B. Evans · 4 shared papers, 2021–2026 · strength 0.69
  6. Mohammed Aldakkak · 3 shared papers, 2025–2026 · strength 0.64
  7. Callisia Nathelee Clarke · 3 shared papers, 2024–2026 · strength 0.60
  8. Ben George · 3 shared papers, 2024–2026 · strength 0.59
  9. Nikki K. Lytle · 2 shared papers, 2026 · strength 0.43
  10. Sam Z. Thalji · 2 shared papers, 2026 · strength 0.43
  11. Thomas B. McFall · 2 shared papers, 2024–2026 · strength 0.38
  12. Razelle Kurzrock · 2 shared papers, 2024–2026 · strength 0.38
  13. X. Allen Li · 3 shared papers, 2019 · strength 0.31
  14. E.S. Paulson · 2 shared papers, 2019–2025 · strength 0.30
  15. Anai N. Kothari · 1 shared paper, 2026 · strength 0.22
  16. Douglas B. Evans · 1 shared paper, 2026 · strength 0.22
  17. Ben George · 1 shared paper, 2026 · strength 0.22
  18. Haidy Gerges Nasief · 2 shared papers, 2019 · strength 0.21
  19. Yongwoo David Seo · 1 shared paper, 2026 · strength 0.21
  20. Rachel A. Burge · 1 shared paper, 2026 · strength 0.21
  21. Daniel Dorbin · 1 shared paper, 2026 · strength 0.21
  22. Channing J. Der · 1 shared paper, 2026 · strength 0.21
  23. G. Aaron Hobbs · 1 shared paper, 2026 · strength 0.21
  24. Jordan R. Kharofa · 1 shared paper, 2025 · strength 0.20
  25. Sara Beltrán Ponce · 1 shared paper, 2025 · strength 0.20

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.